BACKGROUND: The role of microRNAs (miRNAs), a key class of regulators of mRNA expression and translation, in patients with eosinophilic esophagitis (EoE) has not been explored. OBJECTIVE: We aimed to identify miRNAs dysregulated in patients with EoE and assess the potential of these miRNAs as disease biomarkers. METHODS: Esophageal miRNA expression was profiled in patients with active EoE and those with glucocorticoid-induced disease remission. Expression profiles were compared with those of healthy control subjects and patients with chronic (noneosinophilic) esophagitis. Expression levels of the top differentially expressed miRNAs from the plasma of patients with active EoE and patients with EoE remission were compared with those of healthy control subjects. RESULTS: EoE was associated with 32 differentially regulated miRNAs and was distinguished from noneosinophilic forms of esophagitis. The expression levels of the most upregulated miRNAs (miR-21 and miR-223) and the most downregulated miRNA (miR-375) strongly correlated with esophageal eosinophil levels. Bioinformatic analysis predicted interplay of miR-21 and miR-223 with key roles in the polarization of adaptive immunity and regulation of eosinophilia, and indeed, these miRNAs correlated with key elements of the EoE transcriptome. The differentially expressed miRNAs were largely reversible in patients who responded to glucocorticoid treatment. EoE remission induced a single miRNA (miR-675) likely to be involved in DNA methylation. Plasma analysis of the most upregulated esophageal miRNAs identified miR-146a, miR-146b, and miR-223 as the most differentially expressed miRNAs in the plasma. CONCLUSIONS: We have identified a marked dysregulated expression of a select group of miRNAs in patients with EoE and defined their reversibility with glucocorticoid treatment and their potential value as invasive and noninvasive biomarkers.
BACKGROUND: The role of microRNAs (miRNAs), a key class of regulators of mRNA expression and translation, in patients with eosinophilic esophagitis (EoE) has not been explored. OBJECTIVE: We aimed to identify miRNAs dysregulated in patients with EoE and assess the potential of these miRNAs as disease biomarkers. METHODS: Esophageal miRNA expression was profiled in patients with active EoE and those with glucocorticoid-induced disease remission. Expression profiles were compared with those of healthy control subjects and patients with chronic (noneosinophilic) esophagitis. Expression levels of the top differentially expressed miRNAs from the plasma of patients with active EoE and patients with EoE remission were compared with those of healthy control subjects. RESULTS: EoE was associated with 32 differentially regulated miRNAs and was distinguished from noneosinophilic forms of esophagitis. The expression levels of the most upregulated miRNAs (miR-21 and miR-223) and the most downregulated miRNA (miR-375) strongly correlated with esophageal eosinophil levels. Bioinformatic analysis predicted interplay of miR-21 and miR-223 with key roles in the polarization of adaptive immunity and regulation of eosinophilia, and indeed, these miRNAs correlated with key elements of the EoE transcriptome. The differentially expressed miRNAs were largely reversible in patients who responded to glucocorticoid treatment. EoE remission induced a single miRNA (miR-675) likely to be involved in DNA methylation. Plasma analysis of the most upregulated esophageal miRNAs identified miR-146a, miR-146b, and miR-223 as the most differentially expressed miRNAs in the plasma. CONCLUSIONS: We have identified a marked dysregulated expression of a select group of miRNAs in patients with EoE and defined their reversibility with glucocorticoid treatment and their potential value as invasive and noninvasive biomarkers.
Authors: J Pablo Abonia; Carine Blanchard; Bridget Buckmeier Butz; Heather F Rainey; Margaret H Collins; Keith Stringer; Philip E Putnam; Marc E Rothenberg Journal: J Allergy Clin Immunol Date: 2010-06-09 Impact factor: 10.793
Authors: Enikö Sonkoly; Peter Janson; Marja-Leena Majuri; Terhi Savinko; Nanna Fyhrquist; Liv Eidsmo; Ning Xu; Florian Meisgen; Tianling Wei; Maria Bradley; Jan Stenvang; Sakari Kauppinen; Harri Alenius; Antti Lauerma; Bernhard Homey; Ola Winqvist; Mona Ståhle; Andor Pivarcsi Journal: J Allergy Clin Immunol Date: 2010-07-31 Impact factor: 10.793
Authors: Carine Blanchard; Emily M Stucke; Karen Burwinkel; Julie M Caldwell; Margaret H Collins; Annette Ahrens; Bridget K Buckmeier; Sean C Jameson; Allison Greenberg; Ajay Kaul; James P Franciosi; Jonathan P Kushner; Lisa J Martin; Philip E Putnam; J Pablo Abonia; Suzanne I Wells; Marc E Rothenberg Journal: J Immunol Date: 2010-03-05 Impact factor: 5.422
Authors: Mark E Hatley; David M Patrick; Matthew R Garcia; James A Richardson; Rhonda Bassel-Duby; Eva van Rooij; Eric N Olson Journal: Cancer Cell Date: 2010-09-14 Impact factor: 31.743
Authors: Sumanth Polikepahad; John M Knight; Arash O Naghavi; Toni Oplt; Chad J Creighton; Chad Shaw; Ashley L Benham; Jong Kim; Benjamin Soibam; R Alan Harris; Cristian Coarfa; Azam Zariff; Aleksandar Milosavljevic; Lakeisha M Batts; Farrah Kheradmand; Preethi H Gunaratne; David B Corry Journal: J Biol Chem Date: 2010-07-14 Impact factor: 5.157
Authors: Wing Pui Tsang; Enders K O Ng; Simon S M Ng; Hongchuan Jin; Jun Yu; Joseph J Y Sung; Tim Tak Kwok Journal: Carcinogenesis Date: 2009-11-19 Impact factor: 4.944
Authors: Li-Fan Lu; Mark P Boldin; Ashutosh Chaudhry; Ling-Li Lin; Konstantin D Taganov; Toshikatsu Hanada; Akihiko Yoshimura; David Baltimore; Alexander Y Rudensky Journal: Cell Date: 2010-09-17 Impact factor: 41.582
Authors: Ronaldo Paolo L Panganiban; Mark H Pinkerton; Saumya Y Maru; Sarah J Jefferson; Alanna N Roff; Faoud T Ishmael Journal: Am J Clin Exp Immunol Date: 2012-11-15
Authors: Justin C Wheeler; Simone Vanoni; Chang Zeng; Lisa Waggoner; Yanfen Yang; David Wu; Jazib Uddin; Rebekah Karns; Leah Kottyan; Vincent Mukkada; Marc E Rothenberg; Simon P Hogan Journal: J Allergy Clin Immunol Date: 2018-12-20 Impact factor: 10.793
Authors: Thomas X Lu; Eun-Jin Lim; John A Besse; Svetlana Itskovich; Andrew J Plassard; Patricia C Fulkerson; Bruce J Aronow; Marc E Rothenberg Journal: J Immunol Date: 2013-01-16 Impact factor: 5.422